Daud, A. N. A., Bergman, J. E. H., Kerstjens-Frederikse, W. S., Groen, H., & Wilffert, B. (2016). The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key? Int J Mol Sci.

Daud, Aizati N. A., Jorieke E. H. Bergman, Wilhelmina S. Kerstjens-Frederikse, Henk Groen, et Bob Wilffert. "The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?" Int J Mol Sci 2016.

Daud, Aizati N. A., et al. "The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?" Int J Mol Sci 2016.